T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RYZ
1026
Ryerson Holding Corp
RYZ
$1.49B
| $28.4M | 0.01% |
2,862,730
+291,920
| +11% | +$3.29M |
|
|
CTRA
1027
DELISTED
Coterra Energy
CTRA
| $28.3M | 0.01% |
956,795
-174,188
| -15% | -$5.48M |
|
|
MR
1028
DELISTED
Montage Resources Corporation Common Stock
MR
| $28.1M | 0.01% |
266,900
+32,953
| +14% | +$5.48M |
|
1029
TransDigm Group
TDG
$68.6B
| $28.1M | 0.01% |
143,054
-3,900
| -3% | -$735K |
|
|
IVAC
1030
DELISTED
Intevac Inc
IVAC
| $28M | 0.01% |
3,607,030
-27,500
| -0.8% | -$206K |
|
|
ZSPH
1031
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $27.8M | 0.01% |
669,171
+277,371
| +71% | +$10.9M |
|
1032
Tyler Technologies
TYL
$12.8B
| $27.7M | 0.01% |
253,200
+2,100
| +0.8% | +$222K |
|
|
CWEI
1033
DELISTED
Clayton Williams Energy, Inc.
CWEI
| $27.6M | 0.01% |
432,575
-26,390
| -6% | -$1.93M |
|
1034
Ribbon Communications
RBBN
$381M
| $27.2M | 0.01% |
1,372,498
-19,900
| -1% | -$352K |
|
1035
Morningstar
MORN
$7.47B
| $27.2M | 0.01% |
420,794
-131,600
| -24% | -$8.72M |
|
|
DYAX
1036
DELISTED
DYAX CORPORATION
DYAX
| $27.2M | 0.01% |
1,931,200
-33,700
| -2% | -$422K |
|
1037
Ralph Lauren
RL
$23.1B
| $27.1M | 0.01% |
146,579
+6,575
| +5% | +$1.14M |
|
|
SRCL
1038
DELISTED
Stericycle Inc
SRCL
| $27M | 0.01% |
206,215
-20,390
| -9% | -$2.57M |
|
1039
Rockwell Automation
ROK
$49.7B
| $27M | 0.01% |
242,620
+10,400
| +4% | +$1.14M |
|
1040
Agnico Eagle Mines
AEM
$90.4B
| $26.9M | 0.01% |
1,078,120
-2,853,280
| -73% | -$74.3M |
|
1041
Helix Energy Solutions
HLX
$1.49B
| $26.9M | 0.01% |
1,238,085
-183,190
| -13% | -$4.36M |
|
1042
Exelixis
EXEL
$12.6B
| $26.7M | 0.01% |
18,560,450
-180,600
| -1% | -$281K |
|
1043
CTS Corp
CTS
$1.79B
| $26.7M | 0.01% |
1,496,010
+52,550
| +4% | +$916K |
|
1044
Valley National Bancorp
VLY
$8.32B
| $26.6M | 0.01% |
2,734,357
+18,976
| +0.7% | +$184K |
|
1045
Vermilion Energy
VET
$1.7B
| $26.5M | 0.01% |
537,660
+244,560
| +83% | +$12.7M |
|
|
KYNB
1046
Kyntra Bio
KYNB
$28.7M
| $26.4M | 0.01% |
+39,149
| New | +$25.2M |
|
1047
DTE Energy
DTE
$29B
| $26.3M | 0.01% |
357,665
+28,094
| +9% | +$1.95M |
|
|
OB
1048
DELISTED
Onebeacon Insurance Group Ltd
OB
| $26M | 0.01% |
1,604,235
| – | – |
|
|
ENV
1049
DELISTED
ENVESTNET, INC.
ENV
| $25.9M | 0.01% |
526,700
+101,900
| +24% | +$4.79M |
|
1050
Domino's
DPZ
$11.6B
| $25.6M | 0.01% |
272,325
+2,437
| +0.9% | +$218K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.